Prevalence and risk factors for clinically significant upper gastrointestinal bleeding in patients with severe acute pancreatitis

Publisher： John Wiley & Sons Inc

E-ISSN： 1751-2980|16|1|37-42

ISSN： 1751-2972

Source： Journal of Digestive Diseases, Vol.16, Iss.1, 2015-01, pp. : 37-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

To investigate the prevalence and risk factors of upper gastrointestinal bleeding (UGIB) in patients with severe acute pancreatitis (SAP).

Related content

Thalidomide "may be a valuable therapeutic option" in patients with severe gastrointestinal bleeding

Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. : 21-21 (1)

Adis International

Access to resources Recommend Favorite

Compared with naproxen, etodolac appears to reduce the risk of clinically significant upper GI events

Inpharma, Vol. 1, Iss. 1465, 2004-01 ,pp. : 16-16 (1)

Adis International

Access to resources Recommend Favorite

Guidelines for the diagnosis and treatment of acute non‐variceal upper gastrointestinal bleeding (2015, Nanchang, China)

Journal of Digestive Diseases, Vol. 17, Iss. 2, 2016-02 ,pp. : 79-87 (9)

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Impact of Clinical Risk Factors in the Conversion from Acute Lung Injury to Acute Respiratory Distress Syndrome in Severe Multiple Trauma Patients

By Wu JS Sheng L Wang SH Gu J Ma YF Zhang M Gan JX Xu SW Zhou W Xu SX Li Q Jiang GY

The Journal of International Medical Research, Vol. 36, Iss. 3, 2008-05 ,pp. : 579-586 (8)

Field House Publishing

Access to resources Recommend Favorite

Treat non-variceal upper gastrointestinal haemorrhage with proton pump inhibitors and, if the risk of bleeding recurrence is high, endoscopic therapy

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 25, Iss. 5, 2009-05 ,pp. : 13-16 (4)

Adis International

Access to resources Recommend Favorite